Publicacións nas que colabora con Francisco Javier Álvarez-Cienfuegos Suárez (22)

2015

  1. Cardiometabolic Profile Related to Body Adiposity Identifies Patients Eligible for Bariatric Surgery More Accurately than BMI

    Obesity Surgery, Vol. 25, Núm. 9, pp. 1594-1603

2011

  1. Association of increased Visfatin/PBEF/NAMPT circulating concentrations and gene expression levels in peripheral blood cells with lipid metabolism and fatty liver in human morbid obesity

    Nutrition, Metabolism and Cardiovascular Diseases, Vol. 21, Núm. 4, pp. 245-253

2009

  1. Increased adipose tissue expression of lipocalin-2 in obesity is related to inflammation and matrix metalloproteinase-2 and metalloproteinase-9 activities in humans

    Journal of Molecular Medicine, Vol. 87, Núm. 8, pp. 803-813

  2. RIP140 gene and protein expression levels are downregulated in visceral adipose tissue in human morbid obesity

    Obesity Surgery, Vol. 19, Núm. 6, pp. 771-776

2008

  1. Expression of caveolin-1 in human adipose tissue is upregulated in obesity and obesity-associated type 2 diabetes mellitus and related to inflammation

    Clinical Endocrinology, Vol. 68, Núm. 2, pp. 213-219

  2. Influence of morbid obesity and insulin resistance on gene expression levels of AQP7 in visceral adipose tissue and AQP9 in liver

    Obesity Surgery, Vol. 18, Núm. 6, pp. 695-701

2007

  1. Influence of waist circumference on the metabolic risk associated with impaired fasting glucose: Effect of weight loss after gastric bypass

    Obesity Surgery, Vol. 17, Núm. 5, pp. 585-591

  2. Plasma osteopontin levels and expression in adipose tissue are increased in obesity

    Journal of Clinical Endocrinology and Metabolism, Vol. 92, Núm. 9, pp. 3719-3727

  3. The obestatin receptor (GPR39) is expressed in human adipose tissue and is down-regulated in obesity-associated type 2 diabetes mellitus

    Clinical Endocrinology, Vol. 66, Núm. 4, pp. 598-601

  4. Validation of endogenous control genes in human adipose tissue: Relevance to obesity and obesity-associated type 2 diabetes mellitus

    Hormone and Metabolic Research, Vol. 39, Núm. 7, pp. 495-500

2006

  1. Increased cardiovascular risk markers in obesity are associated with body adiposity: Role of leptin

    Thrombosis and Haemostasis, Vol. 95, Núm. 6, pp. 991-996

2005

  1. Leptin therapy does not affect inflammatory markers [2] (multiple letters)

    Journal of Clinical Endocrinology and Metabolism

2004

  1. Bariatric surgery: a NICE example of efficiency and equity

    BMJ (CLINICAL RESEARCH EDITION)

  2. Fasting plasma ghrelin concentrations 6 months after gastric bypass are not determined by weight loss or changes in insulinemia

    Obesity Surgery, Vol. 14, Núm. 9, pp. 1208-1215

  3. Gene expression profile of omental adipose tissue in human obesity.

    The FASEB journal : official publication of the Federation of American Societies for Experimental Biology, Vol. 18, Núm. 1, pp. 215-217

  4. Ghrelin and gastric bypass (multiple letters)

    Obesity Surgery

  5. The decrease in plasma ghrelin concentrations following bariatric surgery depends on the functional integrity of the fundus

    Obesity Surgery, Vol. 14, Núm. 5, pp. 606-612

2003

  1. Preventing obesity

    BMJ, Vol. 326, Núm. 7380, pp. 102

  2. Preventing obesity. Doctors underestimate obesity.

    BMJ (Clinical research ed.)

2002

  1. Disruption of the leptin-insulin relationship in obese men 24 hours after laparoscopic adjustable silicone gastric banding

    Obesity Surgery, Vol. 12, Núm. 3, pp. 366-371